Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$736K Buy
11,691
+6,512
+126% +$455K 0.13% 166
2026
Q1
$391K Buy
+5,179
New +$369K 0.1% 199
2025
Q3
Sell
-20,143
Closed -$1.17M 619
2025
Q2
$1.17M Buy
+20,143
New +$1.14M 0.2% 112

Other funds holding NTR

111 Capital's NTR Position: Q2 2026 in Review

111 Capital increased its Nutrien (NTR) stake by 126% in Q2 2026, buying an estimated $455K and bringing the position to 11,691 shares worth $736K. The position accounts for 0.13% of the portfolio, ranked #166.

111 Capital first reported a position in NTR in Q2 2025 and has held it in 3 quarters since. The position peaked at $1.17M in Q2 2025. 732 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • 111 Capital held 11,691 shares of Nutrien worth $736K as of Q2 2026.
  • 111 Capital bought 6,512 Nutrien shares in Q2 2026, an estimated $455K.
  • Nutrien made up 0.13% of 111 Capital's portfolio in Q2 2026, its #166 holding.
  • 111 Capital first reported a position in Nutrien in Q2 2025 and has held it in 3 quarters since.
  • 111 Capital's Nutrien position peaked at $1.17M in Q2 2025.
  • 732 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.